{"nct_id":"NCT04868877","title":"Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination","status":"RECRUITING","status_verified_date":"2025-04","start_date":"2021-04-28","start_date_type":"ACTUAL","primary_completion_date":"2026-03","primary_completion_date_type":"ESTIMATED","completion_date":"2027-03","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRUS"]}